Cargando…
Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
PURPOSE: Citrate synthase (CS) is a rate-limiting enzyme in the citrate cycle and is capable of catalyzing oxaloacetate and acetyl-CoA to citrate. CS has been uncovered to be upregulated in a variety of cancers, and its expression and clinical significance in prostate cancer (PCa) remain unknown. ME...
Autores principales: | Cai, Zhiduan, Deng, Yulin, Ye, Jianheng, Zhuo, Yangjia, Liu, Zezhen, Liang, Yingke, Zhang, Hui, Zhu, Xuejin, Luo, Yong, Feng, Yuanfa, Liu, Ren, Chen, Guo, Wu, Yongding, Han, Zhaodong, Liang, Yuxiang, Jiang, Funeng, Zhong, Weide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398875/ https://www.ncbi.nlm.nih.gov/pubmed/32801864 http://dx.doi.org/10.2147/CMAR.S255817 |
Ejemplares similares
-
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
por: Han, Zhaodong, et al.
Publicado: (2022) -
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023) -
A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism
por: Liu, Ren, et al.
Publicado: (2021) -
Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022) -
Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential
por: Zhang, Hui, et al.
Publicado: (2021)